Copy into your RSS Reader
Copy into your Podcast App
Cover art from Stoned.
July 14, 2015 Dr. David Casarett used to think of medical marijuana as "a joke." But after taking a deeper look, he's changed his mind. Casarett's new book is Stoned: A Doctor's Case for Medical Marijuana.
<iframe src="http://www.npr.org/player/embed/422876973/422933132" width="100%" height="290" frameborder="0" scrolling="no">
The dream of epilepsy research, says neurobiologist Ivan Soltesz, is to stop seizures by manipulating only some brain cells, not all.
Steve Zylius/UC Irvine Communications
April 18, 2014 Ivan Soltesz studies epilepsy in mice, but says children with chronic seizures are his inspiration. He's closing in on a way to quell the seizures with light — and without drugs' side effects.
<iframe src="http://www.npr.org/player/embed/304353388/304574164" width="100%" height="290" frameborder="0" scrolling="no">
Marilyn Budzynski takes care of her 20-year-old son, Michael, in Eustis, Fla., in September. Michael suffers from Dravet syndrome, a severe form of epilepsy.
Tom Benitez/MCT /Landov
January 16, 2014 This variety of the drug has very little of the primary component that produces the high. Families have been moving to Colorado to get access to the therapy.
<iframe src="http://www.npr.org/player/embed/262481852/262946994" width="100%" height="290" frameborder="0" scrolling="no">
In epilepsy, the normal behavior of brain neurons is disturbed. The drug valproic acid appears to help the brain replenish a key chemical, preventing seizures.
David Mack/Science Source
November 6, 2013 Valproic acid has been a mainstay of epilepsy treatment for decades. But how the drug works has been a mystery. Researchers have now figured out the drug boosts a particular chemical in the brain. The finding may help scientists develop better treatments someday.
NPR thanks our sponsors
Become an NPR sponsor